Armata Pharmaceuticals Q1 EPS $(0.69) Misses $(0.31) Estimate, Sales $966.00K Miss $1.10M Estimate
Armata Pharmaceuticals Q1 EPS $(0.69) Misses $(0.31) Estimate, Sales $966.00K Miss $1.10M Estimate
Armata Pharmaceuticals第一季度每股收益美元（0.69美元）未達到預期（0.31美元），銷售額爲96.00萬美元，低於110萬美元的預期
Armata Pharmaceuticals (AMEX:ARMP) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate of $(0.31) by 122.58 percent. This is a 72.5 percent decrease over losses of $(0.40) per share from the same period last year. The company reported quarterly sales of $966.00 thousand which missed the analyst consensus estimate of $1.10 million by 12.18 percent. This is a 21.36 percent increase over sales of $796.00 thousand the same period last year.
Armata Pharmicals（美國證券交易所股票代碼：ARMP）公佈的季度虧損爲每股0.69美元（0.69美元），比分析師普遍預期的0.31美元（0.31美元）低122.58％。這比去年同期每股虧損0.40美元（0.40）下降了72.5％。該公司公佈的季度銷售額爲96.6萬美元，比分析師普遍預期的110萬美元低12.18％。這比去年同期的79.6萬美元的銷售額增長了21.36％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。